Evidence map›Paper›PMID 28112994›Full record

ArticleMedical decision making : an international journal of the Society for Medical Decision Making2017

Regulator Loss Functions and Hierarchical Modeling for Safety Decision Making.

Laura A Hatfield, Christine M Baugh, Vanessa Azzone, Sharon-Lise T Normand

Abstract read
In one paragraph

Article in Medical decision making : an international journal of the Society for Medical Decision Making, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. MEASURING PERFORMANCE FOR END-OF-LIFE CARE.The annals of applied statistics · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Laura A HatfieldDepartment of Health Care Policy, Harvard Medical School, Boston, MA, USA (LAH, VA).
Christine M BaughInterfaculty Initiative in Health Policy, Harvard University, Cambridge, MA, USA (CMB).
Vanessa AzzoneDepartment of Health Care Policy, Harvard Medical School, Boston, MA, USA (LAH, VA).
Sharon-Lise T NormandDepartment of Health Care Policy, Harvard Medical School and Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA (S-LTN).

Funding

Health Policy Training Program: Promoting Outcomes, Quality, Equity and Diffusion of AdvancesT32MH019733 · NIMH · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI Benjamin Le Cook, Haiden A Huskamp · 1993 to 2026
$7.0M
THE MDEPINET MEDICAL COUNTER MEASURES STUDYU01FD004493 · FDA · HARVARD MEDICAL SCHOOL · PI NORMAND, SHARON-LISE TERESA, RESNIC, FREDERIC S · 2012 to 2012
$1.6M
FDA HHS U01 FD004493NIMH NIH HHS T32 MH019733
6 · The paper itself

Abstract

backgroundRegulators must act to protect the public when evidence indicates safety problems with medical devices. This requires complex tradeoffs among risks and benefits, which conventional safety surveillance methods do not incorporate.

objectiveTo combine explicit regulator loss functions with statistical evidence on medical device safety signals to improve decision making.

methodsIn the Hospital Cost and Utilization Project National Inpatient Sample, we select pediatric inpatient admissions and identify adverse medical device events (AMDEs). We fit hierarchical Bayesian models to the annual hospital-level AMDE rates, accounting for patient and hospital characteristics. These models produce expected AMDE rates (a safety target), against which we compare the observed rates in a test year to compute a safety signal. We specify a set of loss functions that quantify the costs and benefits of each action as a function of the safety signal. We integrate the loss functions over the posterior distribution of the safety signal to obtain the posterior (Bayes) risk; the preferred action has the smallest Bayes risk. Using simulation and an analysis of AMDE data, we compare our minimum-risk decisions to a conventional Z score approach for classifying safety signals.

resultsThe 2 rules produced different actions for nearly half of hospitals (45%). In the simulation, decisions that minimize Bayes risk outperform Z score-based decisions, even when the loss functions or hierarchical models are misspecified. LIMITATIONS: Our method is sensitive to the choice of loss functions; eliciting quantitative inputs to the loss functions from regulators is challenging.

conclusionsA decision-theoretic approach to acting on safety signals is potentially promising but requires careful specification of loss functions in consultation with subject matter experts.

Indexed as

Decision MakingModels, TheoreticalSafetyAdultHumansUnited StatesUnited States Food and Drug AdministrationBayesian statistical methodsdatabase analysisdecision analysishierarchical modelsperformance measuressimulation methods

Identifiers

PMID28112994
PMCPMC5462895

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.